Filing Details
- Accession Number:
- 0001225208-13-007844
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-03-18 14:57:23
- Reporting Period:
- 2013-03-15
- Filing Date:
- 2013-03-18
- Accepted Time:
- 2013-03-18 14:57:23
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
810509 | Navidea Biopharmaceuticals Inc. | NAVB | In Vitro & In Vivo Diagnostic Substances (2835) | 311080091 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1278271 | Jerome Mark Pykett | 425 Metro Place North Suite 450 Dublin OH 43017 | Pres. & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2013-03-15 | 1,850 | $2.70 | 355,914 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 1,198 | Indirect | By 401(k) |
Common Stock | 1,100 | Indirect | By IRA |